TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25439614

Group type: EXPERIMENTAL
Intervention: Prompt laser treatment
Number of subjects: 235

Group type: COMPARATOR
Intervention: Deferred laser treatment
Number of subjects: 235
Study: 23819587

Group type: EXPERIMENTAL
Intervention: Community Health Agents (CHA) introduced as part of health systems strengthening and referral improvement.
Number of subjects: 3300

Group type: EXPERIMENTAL
Intervention: Community Health Agents (CHA) with supervisory systems, information and monitoring operations, and logistics support.
Number of subjects: 3300
Study: 21104229

Group type: EXPERIMENTAL
Intervention: Sagopilone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 0
Study: 19309251

Group type: EXPERIMENTAL
Intervention: Pioglitazone plus metformin (15 mg/day for 12 weeks, then increased to 30 mg/day for 16 weeks)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Metformin monotherapy (500 or 750 mg/day)
Number of subjects: 236
Study: 18690935

Group type: EXPERIMENTAL
Intervention: Adenovirus
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Plasmid/liposomes
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Virus vectors
Number of subjects: 146

Group type: COMPARATOR
Intervention: Randomized control patients
Number of subjects: 146
Study: 15041104

Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5 mg
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg
Number of subjects: 561

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 561
Study: 11775087

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (antidepressants)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies (pharmacotherapy with psychotherapy or electroconvulsive therapy)
Number of subjects: 0
Study: 9041902

Group type: EXPERIMENTAL
Intervention: Water-based pillow
Number of subjects: 41

Group type: COMPARATOR
Intervention: Roll pillow
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard pillow (usual pillow)
Number of subjects: 41
Study: 7949101

Group type: EXPERIMENTAL
Intervention: FISH analysis for 12p13 translocations
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: FISH analysis for 12p deletions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: FISH analysis for both del(12p) and 12p13 translocation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Study of YAC clones spanning 12p13 translocation breakpoints
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: FISH analysis using YACs for del(12p)
Number of subjects: 20
Study: 3145972

Group type: EXPERIMENTAL
Intervention: AZT (3'-azido-3'-deoxythymidine)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 29956883

Group type: EXPERIMENTAL
Intervention: Inebilizumab (MEDI-551)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (healthy donor skin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (SLE patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (COPD patients)
Number of subjects: 0
Study: 27135249

Group type: EXPERIMENTAL
Intervention: Prolonged exposure
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: SSRI (escitalopram)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 231
Study: 25491597

Group type: EXPERIMENTAL
Intervention: LCI699 0.5 mg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Eplerenone 100 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: LCI699 (doses > 1 mg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: LCI699
Number of subjects: 99

Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 99
Study: 22406775

Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg/day for 5 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (vitamin B capsules)
Number of subjects: 50
Study: 20422062

Group type: EXPERIMENTAL
Intervention: RAP asthma program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 19024255

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-containing toothpaste
Number of subjects: 14

Group type: COMPARATOR
Intervention: Regular toothpaste
Number of subjects: 14
Study: 16613273

Group type: EXPERIMENTAL
Intervention: Liang's anti‐rheumatism and rheumatoid granule (LARG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wangbi granule
Number of subjects: 80
Study: 11282811

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (25-75 mg, flexible dose)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 9547934

Group type: EXPERIMENTAL
Intervention: Disulfiram 250 mg/day
Number of subjects: 0
Study: 7507052

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 1645
Study: 3193368

Group type: EXPERIMENTAL
Intervention: Short-term speech spectrum display in time-swept mode with vibration amplitude encoding spectral amplitude
Number of subjects: 0

Group type: COMPARATOR
Intervention: LPC-derived vocal tract shape display as a filled bar graph with number of active vibrators encoding cross sectional area
Number of subjects: 0
Study: 31808721

Group type: EXPERIMENTAL
Intervention: Reading intervention for students in the very low word reading proficiency cluster
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Reading intervention for students in the near-adequate word reading proficiency cluster
Number of subjects: 481
Study: 30807767

Group type: EXPERIMENTAL
Intervention: Plasma homocysteine concentrations at the study median of 8.0 μmol/L
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Serum folate
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Plasma homocysteine
Number of subjects: 1228
Study: 28436538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 24303415

Group type: EXPERIMENTAL
Intervention: Combined intratympanic and systemic steroid therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Systemic steroid therapy alone
Number of subjects: 77
Study: 21179101

Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 61
Study: 19258833

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 16758164

Group type: EXPERIMENTAL
Intervention: Endorectal ultrasound
Number of subjects: 45
Study: 15110197

Group type: EXPERIMENTAL
Intervention: Percutaneous myocardial laser revascularization (PMLR) with optimal medical therapy (n = 40)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sham procedure with optimal medical therapy (n = 42)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (PMLR and sham)
Number of subjects: 82
Study: 11951287

Group type: EXPERIMENTAL
Intervention: Informed consent process
Number of subjects: 0
Study: 9753851

Group type: EXPERIMENTAL
Intervention: Coronary heart disease patients
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Males with coronary heart disease
Number of subjects: 56

Group type: COMPARATOR
Intervention: Males control subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Females with coronary heart disease
Number of subjects: 56

Group type: COMPARATOR
Intervention: Females control subjects
Number of subjects: 56
Study: 7924366

Group type: EXPERIMENTAL
Intervention: Infusion of 1000 mL i.v. Ringer's acetate solution during a 40‐min period
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control period (without infusion)
Number of subjects: 12
Study: 2912881

Group type: EXPERIMENTAL
Intervention: Patients with atlanto-occipital fusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Age- and sex-matched controls
Number of subjects: 20
Study: 31418586

Group type: EXPERIMENTAL
Intervention: Cell phone break
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Larger computer screen break
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Paper break
Number of subjects: 414

Group type: COMPARATOR
Intervention: No break
Number of subjects: 414
Study: 28213121

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10/20 mg QD (flexible)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg QD
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 25229836

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) therapy for 10 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Active recovery (10 min of cycling and stretching)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Passive recovery (sitting for 10 min)
Number of subjects: 16
Study: 23296826

Group type: EXPERIMENTAL
Intervention: 36% CP containing 50% RUP (50RUP)
Number of subjects: 239

Group type: COMPARATOR
Intervention: 36% CP containing 36% RUP (36RUP)
Number of subjects: 239

Group type: COMPARATOR
Intervention: corn silage-based growing diet in a drylot (DRYLOT)
Number of subjects: 239
Study: 21695751

Group type: EXPERIMENTAL
Intervention: Five-week exercise and self-management programme
Number of subjects: 48

Group type: COMPARATOR
Intervention: Management under the general practitioner (GP)
Number of subjects: 48
Study: 19139845

Group type: EXPERIMENTAL
Intervention: Irradiated allograft
Number of subjects: 99

Group type: COMPARATOR
Intervention: Non-irradiated allograft
Number of subjects: 99

Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 99
Study: 17005074

Group type: EXPERIMENTAL
Intervention: Garlicin and fosinopril
Number of subjects: 79

Group type: COMPARATOR
Intervention: Fosinopril alone
Number of subjects: 79
Study: 15718041

Group type: EXPERIMENTAL
Intervention: GM1 ganglioside administration to AD fibroblasts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acidic beta-D-galactosidase activity in AD fibroblasts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extent of GM1 hydrolysis in AD fibroblasts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrolysis rate of sphingolipids in AD fibroblasts
Number of subjects: 0
Study: 12923023

Group type: EXPERIMENTAL
Intervention: IVUS guided PCI
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional PCI (coronary angiography)
Number of subjects: 108
Study: 9988392

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (1,000-1,500 IU IM) and FSH (75-100 IU SC) administered every alternate day until puberty and spermatogenesis achieved
Number of subjects: 14
Study: 7551771

Group type: EXPERIMENTAL
Intervention: Group size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-group variability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diversity (variety)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extremity
Number of subjects: 0
Study: 2121564

Group type: EXPERIMENTAL
Intervention: 1600 mg cyclandelate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 800 mg cyclandelate twice daily for 14 days
Number of subjects: 10
Study: 81844

Group type: EXPERIMENTAL
Intervention: Double-blind food challenges
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Skin testing with 1:20 weight/volume concentrations of food extracts by puncture technique
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Skin testing by puncture technique
Number of subjects: 68
Study: 30859220

Group type: EXPERIMENTAL
Intervention: MultiPoint Pacing (MPP)
Number of subjects: 1921

Group type: COMPARATOR
Intervention: Continued biventricular pacing
Number of subjects: 1921

Group type: EXPERIMENTAL
Intervention: MPP programmed with wide LV electrode anatomical separation (MPP-AS)
Number of subjects: 1921

Group type: EXPERIMENTAL
Intervention: MPP programmed with other settings (MPP-Other)
Number of subjects: 1921

Group type: EXPERIMENTAL
Intervention: MPP-AS
Number of subjects: 1921
Study: 28339526

Group type: EXPERIMENTAL
Intervention: Curved glass marked with yellow tape at the midpoint
Number of subjects: 319

Group type: COMPARATOR
Intervention: Unmarked curved glass
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Curved glass marked with ¼, ½ and ¾ volume points
Number of subjects: 319
Study: 25967070

Group type: EXPERIMENTAL
Intervention: Single WEB
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Repeated WEB
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Single IVR
Number of subjects: 1678

Group type: EXPERIMENTAL
Intervention: Repeated IVR
Number of subjects: 1678

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 1678
Study: 21821725

Group type: EXPERIMENTAL
Intervention: Women First! intervention delivered over 6 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Attention-only comparison group
Number of subjects: 74
Study: 22103280

Group type: EXPERIMENTAL
Intervention: Resurfacing hip arthroplasty (R)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional metal-on-metal hip arthroplasty (C)
Number of subjects: 71
Study: 19369910

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 181

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 181
Study: 16733865

Group type: EXPERIMENTAL
Intervention: HBIG (200 IU intravenously every 4 weeks for 3 times from the 28th week)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (same administration schedule as trial group)
Number of subjects: 52
Study: 15663222

Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 11227239

Group type: EXPERIMENTAL
Intervention: Human recombinant Erythropoietin (r‐EPO) administered three times per week for four weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo administered three times per week for four weeks
Number of subjects: 60
Study: 9355712

Group type: COMPARATOR
Intervention: Standard haemodialysis (HD) for 4 hours using holofibre dialyser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (PD) with Verapamil added intraperitoneally at a dose of 10 mg/L/cycle for 36 hours
Number of subjects: 30
Study: 8467614

Group type: EXPERIMENTAL
Intervention: Fasting for 7-10 days followed by a gluten-free vegan diet for 3.5 months and a lactovegetarian diet for 9 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 34
Study: 3896279

Group type: EXPERIMENTAL
Intervention: Nicardipine (10‐30 mg three times a day, mean dose 69.4 mg per day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 31
Study: 31512050

Group type: EXPERIMENTAL
Intervention: Cutting Down Programme (CDP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both CDP and TAU
Number of subjects: 74
Study: 30536161

Group type: EXPERIMENTAL
Intervention: Mineral-rich solution
Number of subjects: 189

Group type: COMPARATOR
Intervention: Normal saline solution (0.9% NaCl)
Number of subjects: 189
Study: 28082531

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg or 1200 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Aspirin 24 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 25475879

Group type: EXPERIMENTAL
Intervention: Bulleted fact sheet summarizing key study information
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Bulleted fact sheet and feedback Q&A session
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard consent procedures
Number of subjects: 144
Study: 23370530

Group type: EXPERIMENTAL
Intervention: Telemedicine-based collaborative care with free telepsychotherapy
Number of subjects: 179
Study: 21317203

Group type: EXPERIMENTAL
Intervention: Trastuzumab monotherapy in step 1
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Combination of trastuzumab and letrozole in step 2
Number of subjects: 13
Study: 19061882

Group type: EXPERIMENTAL
Intervention: Bemiparin (3500 I.U., s.c.)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 16403848

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 0
Study: 12638399

Group type: EXPERIMENTAL
Intervention: Oxycodone 10 mg/Acetaminophen 325 mg (Percocet)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone 20 mg (OxyContin)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 11347285

Group type: EXPERIMENTAL
Intervention: Zinc oxide/glycine cream
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 46
Study: 9572178

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 17
Study: 7723000

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 3280483

Group type: EXPERIMENTAL
Intervention: Low fat diet with increased dietary carbohydrate by 16% of total calories
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control population (not specified)
Number of subjects: 8
Study: 31623934

Group type: EXPERIMENTAL
Intervention: PubMed Clinical Queries narrow search
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Google Scholar
Number of subjects: 3

Group type: COMPARATOR
Intervention: Google Web
Number of subjects: 3

Group type: COMPARATOR
Intervention: PubMed
Number of subjects: 3

Group type: COMPARATOR
Intervention: PubMed Clinical Queries broad search
Number of subjects: 3
Study: 31722152

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg, orally, twice daily for 12 weeks
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo, orally, twice daily for 12 weeks
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 29130876

Group type: EXPERIMENTAL
Intervention: 28 minutes of lab-based hands-off arthroscopy instruction using a cadaver and arthroscopy setup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7 minutes of hands-on arthroscopy instruction in the lab on a cadaver knee
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classroom-based lecture only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hands-on group
Number of subjects: 0
Study: 25024102

Group type: EXPERIMENTAL
Intervention: Lenstar LS 900® biometry
Number of subjects: 200

Group type: COMPARATOR
Intervention: Immersion A-scan US biometry
Number of subjects: 200

Group type: COMPARATOR
Intervention: Comparison of both devices
Number of subjects: 200
Study: 24640656

Group type: EXPERIMENTAL
Intervention: Selective polarized chromotherapy using blue and red light
Number of subjects: 0
Study: 21740540

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) as a diagnostic triage tool
Number of subjects: 226

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Adherence to initial treatment
Number of subjects: 226
Study: 18639269

Group type: EXPERIMENTAL
Intervention: Ureteral stenting
Number of subjects: 220

Group type: COMPARATOR
Intervention: Nonstenting
Number of subjects: 220
Study: 17032101

Group type: EXPERIMENTAL
Intervention: Baseline perceptions of personal control over illness
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (disease-free women)
Number of subjects: 70
Study: 12949689

Group type: EXPERIMENTAL
Intervention: Proproten-100
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard drugs
Number of subjects: 0
Study: 10385494

Group type: EXPERIMENTAL
Intervention: Etanercept (4 or 10 mg/m2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8712392

Group type: EXPERIMENTAL
Intervention: Therapeutic suggestions preoperatively and Robinson Crusoe story intraoperatively
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peter Pan story preoperatively and therapeutic suggestions intraoperatively
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Crusoe story preoperatively and Peter Pan story intraoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Peter Pan story intraoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Crusoe story
Number of subjects: 60
Study: 1650105

Group type: EXPERIMENTAL
Intervention: Lithium Carbonate (LC)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CRB)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sodium Valproate (SV)
Number of subjects: 88
Study: 6407378

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Tetracycline (1982 follow-up)
Number of subjects: 108

Group type: COMPARATOR
Intervention: All three antibiotics
Number of subjects: 108
Study: 30725315

Group type: EXPERIMENTAL
Intervention: Loxoprofen Hydrogel Transdermal Patch (LOX-T)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Loxoprofen Tablet (LOX-O)
Number of subjects: 182
Study: 27837344

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no PRF)
Number of subjects: 102
Study: 26152135

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 0
Study: 24392551

Group type: EXPERIMENTAL
Intervention: Educational intervention based on social cognitive theory
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 138
Study: 21914313

Group type: EXPERIMENTAL
Intervention: Rapid artificial cardiac pacing
Number of subjects: 197

Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 197
Study: 18274830

Group type: EXPERIMENTAL
Intervention: 3D CT assessment of gastric pouch volume
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 3D CT assessment of pouch area
Number of subjects: 3

Group type: COMPARATOR
Intervention: UGI study assessment of pouch area
Number of subjects: 3
Study: 16944966

Group type: EXPERIMENTAL
Intervention: lamivudine/abacavir
Number of subjects: 2279

Group type: COMPARATOR
Intervention: lamivudine/zidovudine/efavirenz (control)
Number of subjects: 2279
Study: 15318291

Group type: EXPERIMENTAL
Intervention: SMFA-D
Number of subjects: 69

Group type: COMPARATOR
Intervention: WOMAC and FFbH-OA
Number of subjects: 69